The Society for Maternal-Fetal Medicine (SMFM) has issued a statement on prenatal acetaminophen use and outcomes in children. The SMFM publications committee reviewed 2 new retrospective cohort studies published in the last year then examined an association between prenatal acetaminophen use and increased risk for adverse neurological outcomes in childhood. After reviewing these studies, the committee concluded:
- The weight of evidence is inconclusive regarding a possible causal relationship between acetaminophen use and neurobehavioral disorders in the offspring.
- Therefore, SMFM continues to advise that acetaminophen be considered a reasonable and appropriate medication choice for the treatment of pain and/or fever during pregnancy.
Society for Maternal-Fetal Medicine (SMFM) Publications Committee, SMFM Statement: Prenatal acetaminophen use and outcomes in children. [Published online ahead of print January 17, 2017]. Am J Obstet Gynecol. doi:10.1016/j.ajog.2017.01.021.
Must Reads in Clinical Guidelines
ACOG: Chronic Hypertension in Pregnancy, Obstet Gynecol; ePub 2019 Jan; Vidaeff, et al
ACOG Guidelines: Pregestational Diabetes Mellitus, Obstet Gynecol; ePub 2018 Dec; ACOG, et al
Management of Early Pregnancy Loss, Obstet Gynecol; ePub 2018 Nov; ACOG
Prophylactic Antibiotic Use in Labor & Delivery, Obstet Gynecol; 2018 Sep; Coleman, et al
USPSTF on Screening for Cervical Cancer, JAMA; 2018 Aug 21; US Preventive Services Task Force